Stocks Hitting 52-Week Highs

by Lisa Levin, Benzinga Editor

September 14, 2016 10:10 AM | 1 min read |

Las Vegas Sands Corp. LVS shares gained 1.6 percent to reach a new 52-week high of $57.45. Argus Research upgraded Las Vegas Sands from Hold to Buy.
Vitae Pharmaceuticals Inc VTAE shares climbed 158 percent to touch a new 52-week high of $20.89. Allergan plc AGN and Vitae Pharmaceuticals reached an agreement by which the former would buy the latter for $21.00 a share in cash.
Exelixis, Inc. EXEL shares touched a new 52-week high of $13.11 after the company disclosed that the EC has approved CABOMETYX tablets for the treatment of advanced renal cell carcinoma following VEGF-targeted therapy.
Seattle Genetics, Inc. SGEN shares rose 4.5 percent to touch a new 52-week high of $54.01. Seattle Genetics shares have climbed 10.49 percent over the past 52 weeks, while the S&P 500 index has increased 8.91 percent in the same period.

Posted In: News Intraday Update Markets Movers 52 Week Highs 52-Week Highs Casinos & Gaming Consumer Discretionary

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.